Thursday, October 25, 2018

The flu: FDA approves fast-acting, single-dose oral medication

Please be wary of any new medication on the market. This is in the class of antivirals that have in the past produced suicidal symptoms in some patients.

https://www.usatoday.com/story/news/health/2018/10/24/fda-approves-single-dose-oral-flu-medicine-baloxavir-genentech-xofluza/1752905002/

Prescribing label
https://www.gene.com/download/pdf/xofluza_prescribing.pdf

No comments: